Comparison of vasodilator potency of adrenomedullin and proadrenomedullin N-terminal 20 peptide in humans
- 8 October 1999
- journal article
- research article
- Published by Elsevier in Life Sciences
- Vol. 65 (20) , 2151-2156
- https://doi.org/10.1016/s0024-3205(99)00480-4
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Proadrenomedullin-Derived PeptidesFrontiers in Neuroendocrinology, 1998
- Vasodilatory effects of B-type natriuretic peptide are impaired in patients with chronic heart failureAmerican Heart Journal, 1998
- Elevation of circulating proadrenomedullin‐N terminal 20‐peptide in thyrotoxicosisClinical Endocrinology, 1997
- Proadrenomedullin NH2-terminal peptide (PAMP)(12–20) has vasodepressor activity in the rat and catLife Sciences, 1997
- Plasma Proadrenomedullin N-Terminal 20 Peptide (PAMP) in Patients with Congestive Heart FailureHormone and Metabolic Research, 1997
- Vasodilatory effects of C-type natriuretic peptide on forearm resistance vessels are distinct from those of atrial natriuretic peptide in chronic heart failure.Circulation, 1994
- Identification and hypotensive activity of proadrenomedullin N-terminal 20 peptide (PAMP)FEBS Letters, 1994
- Immunoreactive Proadrenomedullin N-Terminal 20 Peptide in Human Tissue, Plasma and UrineBiochemical and Biophysical Research Communications, 1994
- Hemodynamic effects of a novel hypotensive peptide, human adrenomedullin, in ratsEuropean Journal of Pharmacology, 1993
- Adrenomedullin: A Novel Hypotensive Peptide Isolated from Human PheochromocytomaBiochemical and Biophysical Research Communications, 1993